NCT02823665View on ClinicalTrials.gov

The Effects of Bariatric Surgeries on Glucose Metabolism

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Post Bariatric SurgeryGastric BypassSleeve GastrectomyHypoglycemia After Gastric Bypass
Interventions
DRUG

Exendin-(9-39)

A physiological study to evaluate the role of GLP-1 on glucose metabolism and insulin secretin after glucose and protein ingestion.

DRUG

Atropine

A physiological study to evaluate the effect of neural activation on insulin secretion and glucose metabolism.

Trial Locations (2)

78207

RECRUITING

Texas Diabetes Institute - University Health System, San Antonio

78229

RECRUITING

South Texas Veterans Health Care System, San Antonio

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER